Phillip Frost - Jul 25, 2022 Form 4 Insider Report for Cocrystal Pharma, Inc. (COCP)

Role: Director
Signature: /s/ Phillip Frost, MD, ET AL
Stock symbol: COCP
Transactions as of: Jul 25, 2022
Transactions value $: $0
Form type: 4
Date filed: 8/3/2022, 04:03 PM
Previous filing: Jun 22, 2022
Next filing: Aug 8, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	COCP	Stock Options (Right to Buy)	Award	$0	+220K		$0.00	220K	Jul 25, 2022	Common Stock	220K	$0.42	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The stock options were issued pursuant to the 2015 Equity Incentive Plan and vest as follows: one-half will vest and become exercisable on July 25, 2023 and the remaining half will vest and become exercisable in eight equal quarterly installments on the last day of March, June, September, and December commencing on September 30, 2023, subject to the reporting person continuing to serve as a director of the Company on each applicable vesting date.

Content

The stock options were issued pursuant to the 2015 Equity Incentive Plan and vest as follows: one-half will vest and become exercisable on July 25, 2023 and the remaining half will vest and become exercisable in eight equal quarterly installments on the last day of March, June, September, and December commencing on September 30, 2023, subject to the reporting person continuing to serve as a director of the Company on each applicable vesting date.